Advertisement

Pharmacy World & Science

, Volume 31, Issue 2, pp 154–157 | Cite as

Provision of medicines information in Australian community pharmacies

  • Agnes Vitry
  • Andrew Gilbert
  • Kathy Mott
  • Deepa Rao
  • Geoff March
Short Research Report

Abstract

Objective To assess the provision of consumer medicines information in Australian community pharmacies. Method Two methods were employed. One was an exit survey involving consumers just leaving a community pharmacy (n = 554). A total of 42 pharmacies from 6 states were selected randomly. Another was a telephone survey conducted with people aged 15 and over (n = 2,005). The sample was stratified by region at the level of capital city, regional urban and rural with minimum quotas for each category. Results In the exit survey, 13 (6.4%) of the 208 respondents collecting a script received written instructions such as the Consumer Medicines Information (CMI), including 7 (15%) receiving their prescription for the first time and 6 (4%) who came for a subsequent supply. In the phone survey, 876 (46%)of the 1,576 respondents who ever get prescriptions or OTC medicines declared they never or rarely receive written information on how to use a medicine apart from what is on the bottle or packaging. Conclusion The strategy of CMI distribution via pharmacies in Australia has failed to reach acceptable levels. Further strategies have to be implemented by the professional and consumer organisations to ensure consumers receive appropriate essential medicine information.

Keywords

Australia Community pharmacy Consumer survey Medicine information Medicine policies Standards of practice 

Notes

Acknowledgements

We acknowledge the contribution of Ms Frances Eltridge (Harrison Health Research) who assisted with the implementation of this study.

Conflicts of interests

None.

Funding

This study was funded through the Third Community Pharmacy Agreement Research and Development Grants Program managed by the Pharmacy Guild of Australia.

References

  1. 1.
    Australian Department of Health, Ageing. The national strategy for quality use of medicines. Canberra: Australian Department of Health and Ageing; 2002.Google Scholar
  2. 2.
    Pharmaceutical Society of Australia. Professional practice standards version 3. Canberra: Pharmaceutical Society of Australia; 2006.Google Scholar
  3. 3.
    Aslani P. Consumer medicine information conundrums. Aust Prescr. 2007;30(5):122–3.Google Scholar
  4. 4.
    Fogg S. Informing the consumer. Aust Prescr. 2003;26(1):2–3.Google Scholar
  5. 5.
    University of South Australia – Quality Use of Medicines and Pharmacy Research Centre. Harrison Health Research, Tony Lawson Consulting, Australia’s Health P/L. Consumer experiences, needs and expectations of community pharmacy. Canberra: Pharmacy Guild of Australia; 2005.Google Scholar
  6. 6.
    Australian College of Pharmacy Practice and Management, Quality Medication Care Pty Ltd., Therapeutics Research Unit, University of Queensland. Final report on the evaluation of the Quality Care Pharmacy Program. Canberra: Pharmacy Guild of Australia; 2005.Google Scholar
  7. 7.
    Brenton M, Snow K, Parr V. Evaluation of the MIC Program: final report. Canberra: Pharmacy Guild of Australia; 2004.Google Scholar
  8. 8.
    Consumers Health Forum of Australia. Making consumer quality use of medicines happen. Canberra: Consumers’ Health Forum of Australia; 2007.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Agnes Vitry
    • 1
  • Andrew Gilbert
    • 1
  • Kathy Mott
    • 1
  • Deepa Rao
    • 1
  • Geoff March
    • 1
  1. 1.Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia

Personalised recommendations